Current location - Trademark Inquiry Complete Network - Trademark inquiry - What are the veterinary drug concept stocks?
What are the veterinary drug concept stocks?

Veterinary drugs refer to substances (including pharmaceutical additives) used to prevent, treat, diagnose animal diseases or purposefully regulate the physiological functions of animals. Veterinary drug concept stocks refer to the stocks of listed companies engaged in the research and development, production, sales and related raw materials of veterinary drugs. So what are the veterinary drug concept stocks?

List of Veterinary Drug Concept Stocks

1. Muyuan Shares (002714), the latest stock price is 81.46 yuan, and the total market value is 306.235 billion: its subsidiary Henan Xinhua Biotechnology Co., Ltd. is engaged in veterinary drugs (including Veterinary biological products) business; animal diagnostic testing services; veterinary technical services; food testing, environmental testing; biological product development.

2. Changchun High-tech (000661), the latest stock price is 492.38 yuan, the total market value is 199.276 billion, and the increase or decrease in the past year is 97.42: the company's main business includes biopharmaceuticals, Chinese patent medicine production, etc.

3. Haid Group (002311), the latest stock price is 64.33 yuan, and the total market value is 106.866 billion: Haid Group has 30 subsidiaries and more than 2,000 employees. In 2008, the group's total output value was 5 billion yuan, making it one of the top ten famous enterprises in China. The "Haida" trademark was rated as a famous trademark in Guangdong Province, and the Haid brand aquatic products were awarded the title of "China Famous Brand" product. In 2008, Haid Group ranked among the “National Key Leading Enterprises in Agricultural Industrialization”.

4. New Hope (000876), the latest stock price is 21.35 yuan, and the total market value is 96.200 billion: it is publicly engaged in the sales of veterinary drugs; the company is a well-deserved leading enterprise in my country's pharmaceutical industry.

5. Dabeinong (002385), the latest stock price is 10.30 yuan, and the total market value is 43.212 billion: the company’s business scope includes sales of drugs and veterinary drugs (the operation of veterinary preventive biological products is strictly prohibited); animal nutrition and health care Product technology development; agricultural information technology development and services; ** processing (limited to branch operations).

6. Shengnong Development (002299), the latest stock price is 28.00 yuan, and the total market value is 34.846 billion: Shengnong’s subsidiary Shengwei Biotech has entered the fields of veterinary drugs, vaccines, disinfection and other fields

7. Biological shares (600201), the latest stock price is 21.39 yuan, the total market value is 24.090 billion, and the increase or decrease in the past year is 3.83: The company's main business is biopharmaceuticals, and its wholly-owned subsidiary Inner Mongolia Biopharmaceutical Factory is the only company in Inner Mongolia Autonomous Region that produces veterinary biological products and livestock and poultry vaccines. products company.

8. Haixiang Pharmaceutical (002099), the latest stock price is 8.88 yuan, and the total market value is 14.374 billion, with an increase or decrease of 32.65% in the past year: the company is mainly engaged in the production of chemically synthesized pharmaceutical raw materials and fine chemicals (including intermediate body). The raw materials produced by the company include human drugs and veterinary drugs. The main products include antibiotics, hypoglycemic drugs, anti-inflammatory and analgesic drugs, anthelmintic drugs, diuretic drugs and other products.

9. China Animal Husbandry Co., Ltd. (600195), the latest stock price is 13.45 yuan, the total market value is 13.660 billion, and the increase or decrease in the past year is 36.67%: the company’s main business is **, animal health product production and sales*, and animal husbandry Production capital trade and import and export business.

10. Tiankang Biological (002100), the latest stock price is 10.88 yuan, the total market value is 11.698 billion, and the increase or decrease in the past year is 1.76: The company is mainly engaged in the production and sales of biological vaccines for livestock and poultry and drugs*.

11. Haili Biotech (603718), the latest stock price is 13.65 yuan, and the total market value is 8.791 billion: Haili Biotech produces vaccines for pigs.

12. Aonong Biotechnology (603363), the latest stock price is 12.68 yuan, the total market value is 8.547 billion, the increase or decrease in the past year is 19.38: The main business of Fujian Aonong Biotechnology Group Co., Ltd. is divided into four sectors , which are respectively the ** business segment, the breeding business segment, the animal health business segment and the raw material trading segment. The company's main products are pig feed. The business includes sales of veterinary drugs*.

13. Lukang Pharmaceutical (600789), the latest stock price is 8.10 yuan, the total market value is 7.130 billion, the increase or decrease in the past year is -27.63: In the evening of November 29, 2016, the company announced that the company will raise additional funds 1.058 billion yuan was added to the main business. The announcement shows that the funds raised will be mainly invested in the human synthetic raw material drug technology upgrade project of the Biomedical Circular Economy Industrial Park, the high-end biological veterinary drug construction project and the specialty fermentation raw material drug construction project.

14. Rip Biotechnology (300119), the latest stock price is 21.87 yuan, the total market value is 8.846 billion, and the increase or decrease in the past year is 39.73%: the company’s main business is veterinary biological products, veterinary preparations, and veterinary raw materials. R&D, production, sales* and technical services. In November 2015, it was announced that the company planned to non-publicly issue no more than 17.8567 million shares to a total of five investors including the 2015 Employee Stock Ownership Plan, Li Shoujun, Liang Wu, Daojie Investment, and Liang Zhaoping, and raise no more than 269 ??million yuan, and the non-public offering price is 15.07 yuan per share. South China Biotechnology is a high-tech enterprise integrating the research and development, production, sales and technical services of veterinary biological products.

15. Pleco (603566), the latest stock price is 22.13 yuan, and the total market value is 7.115 billion: The company is mainly engaged in the research and development, production and sales of animal vaccines and veterinary chemicals*.

16. ST Hanye (600226), the latest stock price is 1.80 yuan, and the total market value is 5.632 billion: the company’s main business is pesticides, veterinary drugs, and zirconium.

17. Yituoli (300381), the latest stock price is 10.62 yuan, and the total market value is 5.204 billion: It was announced on the evening of January 15, 2017 that the company planned to acquire 51 shares of Shiwei Technology for 85.68 million yuan. The counterparty promised the company that the net profits realized by Shiwei Technology in 2016, 2017 and 2018 will be no less than 11 million yuan, 14 million yuan and 17 million yuan respectively. It is reported that the main products of Shiwei Technology are the plant-derived ** additives Boluohui extract and Boluohui powder products, as well as the research, development and production of traditional Chinese veterinary drugs and various plant extract products.

18. Limin Shares (002734), the latest stock price is 12.59 yuan, the total market value is 4.690 billion, and the increase or decrease in the past year is 25.17: Disclosed in the 2019 annual report: In terms of veterinary drugs, the subsidiary Weiyuan Pharmaceutical is A large-scale domestic veterinary drug GMP enterprise integrating R&D, production and sales of veterinary raw materials and preparations, and has passed certifications such as the US FDA, EU CEP, and Australian APVMAGMP. It has an annual production capacity of 80 tons of ivermectin technical material, and its output and export volume rank among the top in the world.

19. East Lake High-tech (600133), the latest stock price is 5.51 yuan, the total market value is 4.383 billion, and the increase or decrease in the past year is 12.66: The company’s Wuhan Zhongbo is mainly engaged in veterinary vaccines, veterinary drugs, fishery drugs, etc.

20. Jinhe Biotechnology Co., Ltd. (002688), the latest stock price is 5.24 yuan, the total market value is 3.329 billion, the increase or decrease in the past year is -26.51: Jinhe Biotechnology Co., Ltd. is a company mainly engaged in pharmaceutical pharmaceutical additives A production and sales enterprise; in September 2016, it was announced that the company used its own funds to borrow a total of no more than 288 million yuan from its holding subsidiary PHARMGATELLC.** to acquire 100 shares of ProtaTek International, Inc. in the United States. Protech Corporation is a veterinary biologics company.

21. Huashen Technology (000790), the latest stock price is 4.46 yuan, the total market value is 2.749 billion, the increase or decrease in the past year is -11.20: The company is dominated by biopharmaceuticals and high-rise steel structures, focusing on Western pharmaceuticals , biopharmaceuticals, animal health pharmaceuticals, manufacturing construction and bioengineering technology application research, development, production and operation of integrated high-tech listed companies.

22. Lvkang Biochemical (002868), the latest stock price is 11.40 yuan, the total market value is 1.772 billion, the increase or decrease in the past year is -12.18: The company is a high-tech company focusing on the research and development, production and sales of veterinary drugs* Enterprise, its business scope covers multiple fields such as veterinary premixes, veterinary raw materials, and food preservatives.

23. Qianjiang Biochemical (600796), the latest stock price is 4.72 yuan, the total market value is 1.423 billion, and the increase or decrease in the past year is -9.11: The company is currently one of the largest biopesticide manufacturers in China. It mainly produces more than 30 series of four major series: Jinggangmycin series of agricultural fungicides, abamectin series of agricultural insecticides, gibberellin series of plant growth regulators, and veterinary drugs flavomycin, colistin sulfate, and salinomycin. product.